{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:54:01Z","timestamp":1789750441001,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.ijantimicag.2015.09.011","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T19:11:33Z","timestamp":1445627493000},"page":"603-609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of pneumonia caused by multidrug-resistant pathogens: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"46","author":[{"given":"Dong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Xia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Gang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Ming","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0155","first-page":"2462","article-title":"Microbial profile of early and late onset ventilator associated pneumonia in the intensive care unit of a tertiary care hospital in Bangalore, India","volume":"7","author":"Golia","year":"2013","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0160","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","author":"American Thoracic Society: Infectious Diseases Society of America","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0165","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3121\/cmr.4.2.138","article-title":"The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature","volume":"4","author":"Falagas","year":"2006","journal-title":"Clin Med Res"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0170","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1586\/ers.12.45","article-title":"Management and prevention of ventilator-associated pneumonia caused by multidrug-resistant pathogens","volume":"6","author":"Grgurich","year":"2012","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0175","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1473-3099(06)70580-1","article-title":"Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections","volume":"6","author":"Li","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0180","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/jac\/39.2.255","article-title":"A reassessment of the in-vitro activity of colistin sulphomethate sodium","volume":"39","author":"Catchpole","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0185","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2165\/00128072-200204070-00004","article-title":"Nebulized antibiotics in cystic fibrosis","volume":"4","author":"Sermet-Gaudelus","year":"2002","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0190","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1517\/13543784.17.7.973","article-title":"Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives","volume":"17","author":"Falagas","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0195","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1179\/joc.2008.20.2.166","article-title":"Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis","volume":"20","author":"Taccetti","year":"2008","journal-title":"J Chemother"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0200","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s15010-009-9148-6","article-title":"Inhaled anti-infective agents: emphasis on colistin","volume":"38","author":"Michalopoulos","year":"2010","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0205","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/cid\/cir934","article-title":"What is the efficacy and safety of colistin for the treatment of ventilator-associated pneumonia? A systematic review and meta-regression","volume":"54","author":"Florescu","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0210","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.rmed.2007.10.011","article-title":"Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study","volume":"102","author":"Michalopoulos","year":"2008","journal-title":"Respir Med"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0215","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1469-0691.2009.03040.x","article-title":"Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study","volume":"16","author":"Korbila","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0220","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1378\/chest.13-1018","article-title":"Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible Gram-negative bacteria","volume":"144","author":"Tumbarello","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0225","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1086\/657242","article-title":"Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case\u2013control study","volume":"51","author":"Kofteridis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0230","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s10156-012-0430-7","article-title":"Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment?","volume":"18","author":"Kalin","year":"2012","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0235","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/1471-2334-11-317","article-title":"A retrospective observational study on the efficacy of colistin by inhalation as compared to parenteral administration for the treatment of nosocomial pneumonia associated with multidrug-resistant Pseudomonas aeruginosa","volume":"11","author":"Naesens","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0240","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ejcdt.2013.05.012","article-title":"Re-emerging of colistin for treatment of nosocomial pneumonia due to Gram negative multi-drug resistant pathogens in critically ill patients","volume":"62","author":"Amin","year":"2013","journal-title":"Egypt J Chest Dis Tuberculosis"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0245","first-page":"29","article-title":"Inhalation plus intravenous colistin versus intravenous colistin alone for treatment of ventilator associated pneumonia","volume":"9","author":"Bogovic","year":"2014","journal-title":"Signa Vitae"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0250","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2253-13-45","article-title":"Adjunctive aerosolized colistin for multi-drug resistant Gram-negative pneumonia in the critically ill: a retrospective study","volume":"13","author":"Doshi","year":"2013","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0255","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.medin.2011.01.013","article-title":"Nebulized colistin treatment of multi-resistant Acinetobacter baumannii pulmonary infection in critical ill patients","volume":"35","author":"P\u00e9rez-Pedrero","year":"2011","journal-title":"Med Intensiva"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0260","series-title":"The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2011"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0265","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0270","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1093\/jac\/dkq360","article-title":"Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria","volume":"65","author":"Rattanaumpawan","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0275","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1128\/AAC.01705-13","article-title":"Pulmonary and systemic pharmacokinetics of inhaled and intravenous colistin methanesulfonate in cystic fibrosis patients: targeting advantage of inhalational administration","volume":"58","author":"Yapa","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0280","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1086\/432583","article-title":"Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"41","author":"Kwa","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0285","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1586\/eri.11.126","article-title":"Aerosolized antibiotics for treating hospital-acquired and ventilator-associated pneumonia","volume":"9","author":"Wood","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0290","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1586\/eri.13.36","article-title":"Delivering antibiotics to the lungs of patients with ventilator-associated pneumonia: an update","volume":"11","author":"Luyt","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0295","first-page":"1008","article-title":"Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii","volume":"28","author":"Levin","year":"1999","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2015.09.011_bib0300","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/374337","article-title":"Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP","volume":"36","author":"Garnacho-Montero","year":"2003","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915003325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915003325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T11:57:17Z","timestamp":1537271837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857915003325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0924857915003325"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.09.011","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of pneumonia caused by multidrug-resistant pathogens: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}